Tamsulosin Hydrochloride
Product Images NDC 67296-1739

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 67296-1739). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

67296 1739 1

Label for Tamsulosin 0.4 mg capsules with a package count of 10. The label includes the NDC 67296-1739-1 and indicates prescription-only status. It lists Macleods Pharmaceuticals Ltd in India as the manufacturer and RedPharm Drug, Inc. in Eden Prairie, MN as the distributor. The expiration date is 09/21 and it provides storage instructions at controlled room temperature (20-25°C).*

FDA Label Image

Label (67296 1739)

Label for Tamsulosin Hydrochloride 0.4 mg capsules, containing 7 capsules. The label shows the NDC 67296-1739-7 and states Rx only. It includes manufacturing information from Macleods Pharmaceuticals Ltd, India, and distribution by RedPharm Drug, Inc., Eden Prairie, MN. The label also lists storage conditions and an expiration date of 05/21.*

FDA Label Image

Cart (Tamsulosin Carton 0.4mg 100s)

Packaging label for Tamsulosin Hydrochloride Capsules, USP 0.4 mg by Macleods Pharma USA, Inc. The label indicates a unit-dose package containing 100 capsules (10 x 10 unit dose), with storage and dosage information, bar code, and manufacturing details including Macleods Pharmaceuticals Ltd., India.*

FDA Label Image

1000 (Tamsulosin Fig 0.4mg 1000s)

Label for Tamsulosin Hydrochloride Capsules, USP 0.4 mg by Macleods Pharma USA. The label shows dosage strength, storage instructions, quantity of 1000 capsules, and manufacturing details for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. It includes NDC 33342-159-44 and dispensing instructions for pharmacists.*

FDA Label Image

100 (Tamsulosin Fig 0.4mg 100s)

Label for Tamsulosin Hydrochloride Capsules, USP 0.4 mg by Macleods Pharma USA. The label includes storage instructions, dosage advisory, and dispensing guidance for 100 capsules. It shows manufacturing details with Macleods Pharmaceuticals Ltd. in India and Macleods Pharma USA in New Jersey.*

FDA Label Image

30 (Tamsulosin Fig 0.4mg 30s)

Label for Tamsulosin Hydrochloride Capsules, USP 0.4 mg, containing 30 capsules. The label includes storage instructions, dosage advisory, and manufacturer information: Macleods Pharma USA, Inc., Plainsboro, NJ, and Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India. Also shown are barcode and safety warnings to keep out of children's reach.*

FDA Label Image

Lab (Tamsulosin Fig 0.4mg 500s)

Label for Tamsulosin Hydrochloride Capsules, USP 0.4 mg, showing a bottle label with 500 capsules. The label includes storage instructions, manufacturer information (Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd.), and dispensing instructions. Barcodes and product NDC 33342-159-15 are visible along with cautionary notes to keep out of reach of children and to dispense with patient information leaflet.*

FDA Label Image

Fig (Tamsulosin Fig 1)

A pharmacokinetic concentration-time graph showing plasma concentration (ng/mL) of Tamsulosin Hydrochloride over 36 hours. The graph compares drug levels in plasma under fasted and fed conditions, indicating higher peak concentration under fasting.*

FDA Label Image

Fig (Tamsulosin Fig 2a)

A line graph depicting mean change over duration of treatment in weeks. The graph compares three groups: 0.8 mg dose, 0.4 mg dose, and placebo. Mean change values decrease over time for the treatment groups, with the 0.8 mg dose showing the greatest reduction, followed by the 0.4 mg dose, and the placebo group showing the least change. Sample sizes for each time point are indicated along the x-axis.*

FDA Label Image

Fig (Tamsulosin Fig 2b)

A line graph showing mean change over duration of treatment in weeks, comparing three groups: 0.8 mg dose, 0.4 mg dose, and placebo. The x-axis represents treatment duration up to 13 weeks, with sample sizes noted at intervals. The y-axis shows mean change values, with separate lines for each treatment group indicated by different markers and a legend.*

FDA Label Image

Fig (Tamsulosin Fig 3a)

A line graph showing mean change in mL/sec over treatment duration in weeks. Three groups are depicted: 0.8 mg treatment dose (circles), 0.4 mg treatment dose (triangles), and placebo (squares). The graph illustrates changes from baseline over 13 weeks, indicating different response trends for each group.*

FDA Label Image

Fig (Tamsulosin Fig 3b)

A line graph depicting mean change in mL/sec over the duration of treatment in weeks. It compares three treatments: 0.8 mg, 0.4 mg, and placebo, showing their effects across various time points during the study.*

FDA Label Image

Str (Tamsulosin Str)

Chemical structure of Tamsulosin Hydrochloride showing its molecular arrangement including aromatic rings, methoxy groups, and hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.